. The CD200 expression in metastatic HNSCC patients. CD200 gene expression of metastatic HNSCC is elevated in comparison to that of non-metastatic tumors (two sample t-test p-value < 0.001) in an independent set of 12 samples on microarrays (GEO accession id, GSE2370). To elucidate a clinical implication of the high CD200 gene expression in head and neck cancer, we downloaded a public dataset of microarray (Affymetrix U95A microarrays) containing 14 non-/metastatic head and neck squamous cell carcinoma from GEO database (accession number: GSE2370). We converted CD200 (probe id: 37716_at) expression level into log2 scale and used two sample t-test with a significance level of 0.01 to test for the difference in mean CD200 expression between non-and metastasis groups. Figure S2 . The EMT features in endogenously CD200-expressing NTERA cell. (A) The CD200 endogenous expression cell line, NTERA-2, was exposed to 20 pmoles of siRNA (scramble or CD200) for 48 hours. The cells were then digested with RIPA buffer and quantitated. Western blot analysis was performed at 30 µ g per sample. The changes of EMT gene by siRNA treatment were detected as anti-CD200, anti-E-cadherin, anti-vimentin and anti-β-actin. (B) siRNA treatment for NTERA-2 is the same as supplementary figure 1b. Then, each 1 × 10 5 cells were added to the matrigel-coated transwell
. The CD200 expression in metastatic HNSCC patients. CD200 gene expression of metastatic HNSCC is elevated in comparison to that of non-metastatic tumors (two sample t-test p-value < 0.001) in an independent set of 12 samples on microarrays (GEO accession id, GSE2370). To elucidate a clinical implication of the high CD200 gene expression in head and neck cancer, we downloaded a public dataset of microarray (Affymetrix U95A microarrays) containing 14 non-/metastatic head and neck squamous cell carcinoma from GEO database (accession number: GSE2370). We converted CD200 (probe id: 37716_at) expression level into log2 scale and used two sample t-test with a significance level of 0.01 to test for the difference in mean CD200 expression between non-and metastasis groups. Figure S2 . The EMT features in endogenously CD200-expressing NTERA cell. (A) The CD200 endogenous expression cell line, NTERA-2, was exposed to 20 pmoles of siRNA (scramble or CD200) for 48 hours. The cells were then digested with RIPA buffer and quantitated. Western blot analysis was performed at 30 µ g per sample. The changes of EMT gene by siRNA treatment were detected as anti-CD200, anti-E-cadherin, anti-vimentin and anti-β-actin. (B) siRNA treatment for NTERA-2 is the same as supplementary figure 1b. Then, each 1 × 10 5 cells were added to the matrigel-coated transwell S2 of S6 and incubated for 48 hours. The invaded cells were stained with crystal violet, and then stained cells were directly counted using a microscope (100 μm scale bar). Each error bar in the graph represents the average of three independent experiments (mean  SEM). Figure S3 . Formation and cisplatin-responsiveness of CD200-overexpressing MEER cell. (A) A different number of each cell type was cultured in a suspension media for 7 days. We then counted under a microscope how many spheres were formed and plotted the results (upper left). Total RNA from each cell line was prepared for SOX2 qRT-PCR analysis (mean  SEM; n = 3). P values were determined by two-tailed paired t-tests (upper right). Cells were cultured in the suspension media and monitored for sphere formation after 7 days (100 μm scale bar, bottom). (B) After 1 × 10 5 cells/well were treated with 1 or 5 µ M cisplatin for 48 h, cell viability by MTS assay was determined as a percentage of cells compared to the no-treatment control (mean  SEM; n = 3) in three independent experiments. Results were analyzed by two-tailed, paired t-tests. Figure S4 . Adenovirus over-expressing soluble extracellular domain of CD200. (A) An adenovirus encoding the extracellular domain of CD200R1, sCD200R1, was constructed as a fusion protein containing the Fc portion of mouse IgG2a as described in the Materials and methods. The Ad5MOCK adenovirus was produced as a control. (B) HEK293 cells were infected with 10 MOI for 24 h to confirm secretion of soluble sCD200R1-Ig into the culture medium. Culture supernatant (Sup.) was collected, and the cells were lysed with RIPA buffer. Total proteins (40 µ g) were resolved for immunoblot analysis. S3 of S6 Figure S5 . Abolition of β-catenin target genes by CD200 siRNA in CD200 endogenous expression cell. NTERA-2 cells were treated with 20 pmoles siRNA and lysed 48 hours later with RIPA buffer. Western blot analysis was performed at 30 µ g per sample. The changes of β-catenin target genes by siRNA treatment were detected as anti-ZEB1, anti-c-MYC and anti-Fibronectin. Supplementary Figures 2A, 4B , 5A.
